Bafna Pharmaceuticals Ltd BAFNAPH-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:22 PM IST
122.20quote price arrow down-0.75 (-0.61%)
Volume
4,092
52 week range
4.40 - 233.55

...

Loading . . .

KEY STATS

  • Open123.35
  • Day High126.90
  • Day Low120.00
  • Prev Close122.95
  • 52 Week High233.55
  • 52 Week High Date12/18/20
  • 52 Week Low4.40
  • 52 Week Low Date03/02/20
  • Market Cap39.75M
  • Shares Out23.66M
  • 10 Day Average Volume4,637.09
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change2,344

RATIOS/PROFITABILITY

  • EPS (TTM)13.14
  • P/E (TTM)9.30
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bafna Pharmaceuticals Ltd News

There is no recent news for this security.

Latest BAFNAPH-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bafna Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the manufacture of drugs and medicines. The Company operates through generic pharmaceutical segment. The Company caters to both domestic and international markets. Its HAEMATINIC products include Raricap, Raricap Forte, Raricap L Suspension, Raricap Combi, Raricap Drops, Raricap M, Raricap Maa and Raricap S Injection. Raricap is indicated for iron deficiency anemia. Raricap Forte is indicated...
Mahaveer Bafna
Chairman
Address
Bafna Towers, 299, Thambu Chetty street
Chennai
600001
India